Literature DB >> 24851730

The use of a surgical incision management system on vascular surgery incisions: a pilot study.

Gregory Weir1.   

Abstract

Health care-associated infections in hospitals, including surgical site infections, contribute significantly to morbidity as well as mortality. Surgical incision management (SIM) using negative pressure wound therapy (Prevena™ Incision Management System, Kinetic Concepts, Inc., San Antonio, TX, USA) is designed to cover and protect closed surgical incisions from external factors including infectious sources and local trauma, while negative pressure removes fluid and infectious material from the surgical incision. A prospective case-control study assessed wound complications in patients undergoing vascular bypass procedures, where both femoral areas were incised to gain access to the femoral arteries. SIM was placed on one femoral area while a standard postoperative wound dressing was placed on the contralateral femoral area. Eight patients were included in this pilot study. All of them required bilateral femoral artery access. During the follow-up period patients were monitored for wound complications. All wound complications requiring surgical intervention were considered significant. No significant wound complications occurred in wounds treated with SIM, compared with three significant complications in control wounds. These preliminary data would suggest a potential reduction in wound complications and no observed increase in haemorrhage in high-risk patients with severe co-morbidities undergoing vascular surgery.
© 2014 The Author. International Wound Journal © 2014 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  SIM; Surgical incision management; Surgical site infection; Vascular surgery

Mesh:

Year:  2014        PMID: 24851730      PMCID: PMC7950625          DOI: 10.1111/iwj.12261

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  2 in total

1.  National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System.

Authors: 
Journal:  Am J Infect Control       Date:  1996-10       Impact factor: 2.918

2.  Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Authors:  R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

  2 in total
  5 in total

1.  Closed-incision negative pressure therapy to reduce groin wound infections in vascular surgery: a randomised controlled trial.

Authors:  Michael Engelhardt; Norah A Rashad; Christian Willy; Christian Müller; Christian Bauer; Sebastian Debus; Tino Beck
Journal:  Int Wound J       Date:  2018-03-12       Impact factor: 3.315

2.  Incisional negative pressure therapy reduces complications and costs in pressure ulcer reconstruction.

Authors:  Anthony A Papp
Journal:  Int Wound J       Date:  2018-12-12       Impact factor: 3.315

Review 3.  Closed incision negative pressure therapy: international multidisciplinary consensus recommendations.

Authors:  Christian Willy; Animesh Agarwal; Charles A Andersen; Giorgio De Santis; Allen Gabriel; Onnen Grauhan; Omar M Guerra; Benjamin A Lipsky; Mahmoud B Malas; Lars L Mathiesen; Devinder P Singh; V Sreenath Reddy
Journal:  Int Wound J       Date:  2016-05-12       Impact factor: 3.315

4.  Reduction of groin wound complications in vascular surgery patients using closed incision negative pressure therapy (ciNPT): a prospective, randomised, single-institution study.

Authors:  Sebastian P Pleger; Nadine Nink; Meshal Elzien; Alexander Kunold; Ahmed Koshty; Andreas Böning
Journal:  Int Wound J       Date:  2017-10-25       Impact factor: 3.315

5.  Modified Incisional Negative Pressure Wound Therapy Increases Seroma Evacuation: An Ex Vivo Model.

Authors:  Matthias Mehdorn; Boris Jansen-Winkeln
Journal:  Biomed Res Int       Date:  2021-10-21       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.